Home » Qiagen Announces Supply Agreement With Veridex
Qiagen Announces Supply Agreement With Veridex
Qiagen announced that its wholly owned subsidiary Qiagen GmbH has entered into a manufacturing and supply agreement with Veridex, a Johnson & Johnson company. Veridex intends to market Qiagen's preanalytical solutions under their GeneSearch trademark and as a component of the diagnostics solutions offered by Veridex.
Canada NewsWire (http://www.newswire.ca/en/releases/archive/April2005/18/c6733.html)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct